The reiteration of the 'Outperform' rating by Wedbush analyst Alicia Reese indicates a positive outlook for Imax. The maintained price target of $26 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.